STOCK TITAN

Innovative Eyewear Inc. Reports Full Year 2025 Financial Results

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Very Positive)
Tags

Innovative Eyewear (NASDAQ: LUCY) reported full year 2025 results: net revenue $2.67M (up 63% year-over-year) and gross margin 21% versus 13% in 2024. Net loss narrowed slightly to $7.59M or $1.90 per share on an expanded share base.

The company highlighted strong unit volume from Lucyd Armor and the Reebok cobranded launch, Q4 revenue of $0.96M (highest quarterly sales to date), no debt, and year-end cash and investments of $6.51M.

Loading...
Loading translation...

Positive

  • Net revenue +63% YoY to $2.67M
  • Gross profit margin improved to 21% (vs 13%)
  • Q4 revenue $0.96M, highest quarterly sales to date
  • Lucyd Armor represented ~50% of smartglass units sold
  • No debt outstanding at December 31, 2025
  • Financing proceeds of $6.68M in 2025

Negative

  • Net loss of $7.59M (EPS $(1.90))
  • Operating expenses increased 11% to $9.06M
  • Cash and investments declined to $6.51M from $7.52M

News Market Reaction – LUCY

%
8 alerts
% News Effect
+19.6% Peak in 8 hr 4 min
$6.05M Market Cap
0.4x Rel. Volume

On the day this news was published, LUCY declined NaN%, reflecting a moderate negative market reaction. Argus tracked a peak move of +19.6% during that session. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Net revenue: $2.67M Revenue growth: 63% Gross profit margin: 21% (vs 13%) +5 more
8 metrics
Net revenue $2.67M Full year 2025 net revenue, up from 2024
Revenue growth 63% Year-over-year increase vs full year 2024
Gross profit margin 21% (vs 13%) Full year 2025 vs full year 2024
Operating expenses $9.06M (up 11%) Total operating expenses in 2025 vs 2024
Net loss $(7.59)M; $(1.90)/share Full year 2025 net loss and loss per share
Cash & investments $6.51M Combined cash, cash equivalents and investments at 12/31/2025
Net working capital $8.39M Current assets minus current liabilities at 12/31/2025
Financing cash flow $6.68M Net cash provided by financing activities in 2025

Market Reality Check

Price: $1.0800 Vol: Volume 67,535 is close to...
normal vol
$1.0800 Last Close
Volume Volume 67,535 is close to the 20-day average of 71,139, suggesting typical trading interest ahead of these results. normal
Technical Shares at $1.09 are trading below the 200-day MA of $1.70 and about 80% under the 52-week high of $5.56.

Peers on Argus

LUCY gained 2.73% while key peers were mixed: EKSO up 3.49%, but FEMY, MHUA, HBI...
1 Down

LUCY gained 2.73% while key peers were mixed: EKSO up 3.49%, but FEMY, MHUA, HBIO and GCTK declined, with MHUA down 27.18%. Current action appears stock-specific, not a broad ophthalmic/medical devices move.

Previous Earnings Reports

5 past events · Latest: Nov 13 (Positive)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Nov 13 Q3 2025 earnings Positive -12.4% Reported strong Q3 and nine‑month revenue growth with higher gross margins.
Aug 14 Q2 2025 earnings Positive -6.8% Announced 88% YoY revenue growth but pressure on gross margins and ongoing losses.
May 13 Q1 2025 earnings Positive +46.5% Showed revenue growth and major gross margin improvement with narrower net loss.
Mar 25 FY 2024 results Positive -3.6% Reported 42% revenue growth and margin gains but higher operating expenses and losses.
Jan 15 Event participation Neutral -1.1% Outlined participation in multiple industry events to showcase smart eyewear tech.
Pattern Detected

Earnings-related news has often seen volatile and frequently negative next-day moves, even when reporting strong revenue growth and margin improvement, with only one recent earnings release producing a large positive reaction.

Recent Company History

Over the past year, LUCY’s earnings releases have consistently highlighted strong revenue growth and improving gross margins. The prior full-year 2024 report on Mar 25, 2025 showed a 42% revenue increase and margin improvement, but the stock fell. Subsequent Q1–Q3 2025 updates reported rapid sales growth and better margins, yet reactions were mixed, including sharp declines after Q2 and Q3. Today’s full-year 2025 results continue this theme of scaling revenue while remaining loss-making.

Historical Comparison

+4.5% avg move · In the past year, LUCY issued 4 core earnings updates and 1 earnings-tagged event. The average next-...
earnings
+4.5%
Average Historical Move earnings

In the past year, LUCY issued 4 core earnings updates and 1 earnings-tagged event. The average next-day move was about 4.52%, often skewed by sharp swings. Today’s reaction sits within this historically volatile range for earnings news.

Earnings releases show a progression from FY 2024’s 42% growth to accelerating 2025 quarterly gains, with recurring emphasis on Lucyd Armor and Reebok lines and steady gross margin improvement over time.

Market Pulse Summary

This announcement highlights substantial full-year revenue growth of 63%, improved gross margin to 2...
Analysis

This announcement highlights substantial full-year revenue growth of 63%, improved gross margin to 21%, and continued net losses of $(7.59)M as LUCY invests in product and market expansion. Compared with prior earnings updates, the story of scaling Lucyd Armor and Reebok-branded smart eyewear continues. Investors may focus on how quickly operating expenses of $9.06M moderate relative to sales, cash and investment levels of $6.51M, and whether margin gains prove durable.

Key Terms

ansi z87.1+, csa z94.3
2 terms
ansi z87.1+ technical
"with all necessary safety certifications including ANSI Z87.1+, CSA Z94.3, and EN 16639:2018."
ANSI Z87.1+ is a U.S. safety standard for eye and face protection; the Z87.1 marking means the product meets baseline impact and coverage tests, and the "+" indicates it passed higher-impact or more stringent protection tests. Investors should care because certification affects a product’s legal compliance, market access, customer trust and liability exposure—similar to a car having airbag crash-test ratings, higher safety marks can drive sales and reduce regulatory or recall risk.
csa z94.3 technical
"with all necessary safety certifications including ANSI Z87.1+, CSA Z94.3, and EN 16639:2018."
CSA Z94.3 is a Canadian safety standard that defines performance, testing and labelling requirements for protective eyewear and face shields to guard against impacts, chemical splashes and harmful light. Investors should care because certification acts like a recognized safety “stamp of approval” that lets manufacturers sell into regulated workplaces and healthcare settings, reduces product liability and can drive procurement decisions, affecting sales, margins and market access.

AI-generated analysis. Not financial advice.

Revenue increased 63% over prior year

Gross Profit Margins increased by 8 percentage points despite tariff headwinds

MIAMI, March 25, 2026 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ: LUCY, LUCYW), the developer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, today announced its full year 2025 financial results.

Net revenue for the year ended December 31, 2025 was approximately $2.67 million, an increase of $1.03 million or 63% from the year ended December 31, 2024. This strong year-over-year revenue growth was primarily driven by volume increases from sales of the Company's highly successful Lucyd Armor® smart safety glasses (first launched in October 2024), which represented approximately half of the Company's total smartglass units sold in the current year. The cobranded Reebok® Powered by Lucyd collection, which launched in April 2025, also contributed to the year-over-year volume increases. Total net revenue for the fourth quarter of 2025 was approximately $0.96 million, representing the highest quarterly sales amount since the Company's inception.

Gross profit margin for 2025 was 21%, compared to 13% for 2024. This improvement in gross profit margin was primarily attributable to lower product sourcing costs for both frames and prescription lenses as the Company continues to scale and develop its business. These improvements were partially offset by the negative impacts of tariffs during the current year, as well as provisions for certain excess, obsolete, and slow-moving inventory. Although tariffs had a negative impact on current year margins, various actions taken by management to help mitigate the impact of tariffs have generally been successful thus far, and by the end of 2025 had largely restored gross profit margins to a level consistent with the Company's pre-tariff business plan expectations. Management continues to monitor international trade policy and develop contingency sourcing options should tariff and international trade conditions materially change.

Total operating expenses in 2025 were approximately $9.06 million, an increase of $0.92 million or 11% from 2024. This increase was primarily driven by higher general administrative expenses, which increased by approximately $0.75 million year-over-year primarily due to the combination of higher employee compensation costs as the Company has expanded its team to fuel and support further growth, and higher license fees paid under multi-year cobranded license agreements. Sales and marketing expenses increased by approximately $0.26 million from prior year, primarily driven by increased spending on events and trade shows, as the Company grows and expands its network of potential business partners and retailers.

The Company also recognized approximately $0.90 million of other non-operating income during the current year, primarily driven by the receipt of a $0.57 million settlement payment related to certain legal matters; the remaining amount of other income mainly related to interest and dividends earned on investments in U.S. Treasury bills and money market funds.

The Company's net loss for 2025 was approximately $(7.59) million or $(1.90) per share, compared with $(7.77) million or $(5.19) per share in the prior year, reflecting the Company's continued investment in product development and market expansion to support further growth. Weighted average shares outstanding for the years ended December 31, 2025 and 2024 were approximately 3.99 million and 1.50 million, respectively.

The Company ended the year with approximately $6.51 million of combined cash and cash equivalents and investments, compared with $7.52 million of combined cash and cash equivalents and investments as of December 31, 2024. Net working capital (current assets less current liabilities) was $8.39 million at December 31, 2025, and $8.50 million at the end of 2024. The Company had no debt outstanding as of December 31, 2025, and long-term liabilities of only $0.03 million.

The Company generated significant amounts of proceeds from multiple equity offerings during both the current and prior year. Net cash flows provided by financing activities were $6.68 million in 2025 and $10.24 million in 2024.

Additionally, during the fourth quarter of 2025, Innovative Eyewear announced several important milestones related to its product portfolio and distribution network, including:

  • Launched three additional new variants of the extremely popular Lucyd Armor smart safety glasses, in order to expand the collection to a wider audience and build on the success of the original model with important variations in lens functionality and sizing. The Armor Slim model recently received ANSI certification, enabling it to be sold in the U.S. for safety applications. Lucyd Armor is currently available for purchase in the United States, Canada, and European Union markets, with all necessary safety certifications including ANSI Z87.1+, CSA Z94.3, and EN 16639:2018.
  • Launched two new light-adaptive sport smartglass models in the Reebok Powered by Lucyd collection, designed for use in the gym and indoor sports. The Reebok smart eyewear collection offers the Company's most powerful music experience to-date, with an end-to-end overhauled sound system developed with leading audio engineers.
  • Announced a new partnership with SmartBuyGlasses, one of the largest global online independent sellers of prescription, standard, and designer eyewear, to provide its Reebok smart eyewear to customers.

Harrison Gross, CEO of Innovative Eyewear Inc., commented, "I am very pleased by our impressive sales growth for the year. We continue our upward trend of outperforming sales each quarter on a year-over-year basis, which we have done every quarter for over two years now. I am also pleased by the overall improvements in our gross profit margin during the year, despite headwinds from tariffs. We plan to build on the continued success and momentum of our most popular product lines, Lucyd Armor® smart safety glasses, Lucyd Lyte®, and Reebok® Powered by Lucyd smartglasses. We are also excited about the potential of international growth and expansion, as we continue to make progress towards building a more globally focused business with significant distribution outside of the U.S. In summary, we believe that we are well positioned to deliver further revenue growth in 2026 and beyond."

About Innovative Eyewear, Inc.

Innovative Eyewear is a developer & manufacturer of cutting-edge ChatGPT enabled smart eyewear, under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands. True to our mission to Upgrade Your Eyewear®, our Bluetooth audio glasses allow users to stay safely and ergonomically connected to their digital lives and are offered in hundreds of frame and lens combinations to meet the needs of the optical, sunglass, sporting goods and safety eyewear markets. To learn more and explore our continuously evolving collection of smart eyewear, please visit www.lucyd.co.

Forward-Looking Statements

This press release contains certain forward-looking statements, including those relating to the Company's business operations, projections, market position, revenue growth, future product lines and developments. Forward-looking statements are based on the Company's current expectations and assumptions. The Private Securities Litigation Reform Act of 1995 provides a safe-harbor for forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "anticipate," "believe," "continue," "estimate," "expect," "future," "intend," "may," "outlook," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K under the caption "Risk Factors."

Investor Relations Contact:

Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: +1 (646) 893-5835
Email: info@skylineccg.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-eyewear-inc-reports-full-year-2025-financial-results-302725172.html

SOURCE Innovative Eyewear, Inc.

FAQ

What were Innovative Eyewear (LUCY) full-year 2025 revenues and growth?

LUCY reported $2.67M in net revenue for 2025, a 63% increase year-over-year. According to the company, growth was driven mainly by Lucyd Armor volume and the April 2025 Reebok cobranded collection.

How did Innovative Eyewear's gross margin change in 2025 for LUCY stockholders?

Gross margin rose to 21% in 2025 from 13% in 2024, an 8 percentage-point improvement. According to the company, margin gains came from lower sourcing costs partly offset by tariff impacts and inventory provisions.

What was Innovative Eyewear's profitability and EPS for 2025 (LUCY)?

The company reported a net loss of $7.59M, or $1.90 per share for 2025. According to the company, ongoing investments in product development and market expansion drove the loss despite revenue growth.

How strong was Innovative Eyewear's quarter-to-date performance in Q4 2025 for LUCY?

Q4 2025 net revenue was approximately $0.96M, the highest quarterly sales in company history. According to the company, new Lucyd Armor variants and cobranded product launches supported the quarterly record.

What is Innovative Eyewear's cash, debt, and financing status at year-end 2025 (LUCY)?

The company ended 2025 with $6.51M in cash and investments and reported no debt outstanding. According to the company, net cash from financing was $6.68M in 2025, supporting operations and growth.
Lucyd Inc

NASDAQ:LUCY

View LUCY Stock Overview

LUCY Rankings

LUCY Latest News

LUCY Latest SEC Filings

LUCY Stock Data

5.83M
4.61M
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
MIAMI